The Latest Breaking News from biotechnology

The Chart of the Day belongs to the biotechnology company Argenx (ARGX) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart feature...

India can become a leading player in the field of biomanufacturing and help the Quad, of India, Japan, Australia and the United States, to compete in this key area

Coupled with fears about an economic downturn, several other headwinds could keep the biotechnology industry under significant pressure. Given this backdrop, fundamentally weak biotech stocks Day One Biopharmaceuticals (DAWN), Northwest Biotherapeutics (NWBO), and Ocugen (OCGN), with bearish momentum, could be avoided in April. Read on….

Saudi Arabia and South Korea are working to develop a comprehensive strategic cooperation, especially in the field of petrochemicals, energy supply chains, and the exchange of expertise and technological industries, with Seoul expressing interest in more vital partnerships that would also cover biotechnology industries and startups. Lee Young, South Korean…

Frank did not grow up as son of a Wall Street banker. He began as the consummate outsider.

The Chart of the Day belongs to the biotechnology company Aldeyra Therapeutics (ALDX) . I found the stock by using Barchart's powerful screening functions to find stocks with the highest technical buy signals, highest Weighted Alpha, superior current momentum and having a Trend Seeker buy signal then used the Flipchart...

The biotech industry is predicted to grow steadily, driven by significant advancements, advancements in agriculture, biotechnology, and government initiatives. Also, during market downturns, the biotech sector tends to be more defensive than others. So, LAVA Therapeutics (LVTX) could be an ideal buy now. However, considering the lingering macroeconomic headwinds, fundamentally…

As March comes to an end, biotech stocks Exelixis (EXEL), MacroGenics (MGNX), and Puma Biotechnology (PBYI) have been losing momentum. However, given the long-term prospects of the biotechnology industry and the administration’s push to boost domestic biomanufacturing, these biotech stocks could prove to be solid long-term investments. Read more.

The biotech industry is growing with considerable developments and government initiatives. Given the solid prospects of the industry, fundamentally sound biotech stocks Vertex Pharmaceuticals (VRTX), Biogen (BIIB), Exelixis (EXEL), and Cidara Therapeutics (CDTX) could be excellent buys. Keep reading.